Current PSA level-Between 1 to 4 - Page 3 of 4 Posts on Medivizor
Navigation Menu

Current PSA level-Between 1 to 4 Posts on Medivizor

Looking for prostate cancer patients to evaluate the benefits of hypo-fractionated radiation therapy

Posted by on Aug 7, 2015 in Prostate cancer | 0 comments

In a nutshell This phase III trial aims to determine the effects of hypo-fractionated radiation compared to standard radiation therapy. The main outcome to be investigated is whether hypo-fractionated radiation has similar or better results when compared to standard radiation. This trial is recruiting in in Illinois, Oklahoma and Virginia, in the...

Read More

Health factors used to predict patient outcome following radiation therapy in prostate cancer

Health factors used to predict patient outcome following radiation therapy in prostate cancer

Posted by on Mar 10, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine if a new risk classification system could help determine treatment and outcome in individuals with intermediate-risk prostate cancer.  Some background External-beam radiation therapy (EBRT) is a form of treatment that involves the application of an external radiation source focused at the site of...

Read More

Statin use is associated with freedom from rising levels of PSA after radiation therapy

Statin use is associated with freedom from rising levels of PSA after radiation therapy

Posted by on Dec 2, 2014 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether statin use can prevent prostate cancer recurrence after brachytherapy.  Some background Brachytherapy is a form of radiation, where a radiation source is internally placed at the tumor site. It is sometimes given in combination with external beam radiation therapy (EBRT – radiation...

Read More

Is your current prostate biopsy doing enough?

Is your current prostate biopsy doing enough?

Posted by on Aug 18, 2014 in Prostate cancer | 0 comments

In a nutshell The authors evaluated the usefulness of transition zone prostate biopsy in prostate cancer patients undergoing active surveillance. Some background The peripheral zone of the prostate is the area of the prostate that is closest to the rectum, and is easily felt by the doctor during a digital rectal examination....

Read More

Can ERG protein expression be used to identify progression risk during active surveillance?

Can ERG protein expression be used to identify progression risk during active surveillance?

Posted by on May 18, 2014 in Prostate cancer | 0 comments

In a nutshell This article examined the association between ERG expression at prostate cancer diagnosis and the risk of disease progression during active surveillance. Some background One of the largest dilemmas in the treatment of prostate cancer is the management of a localized low-risk disease. Since radical prostatectomy (surgery to remove the...

Read More

Treatment options for prostate cancer recurrence

Treatment options for prostate cancer recurrence

Posted by on Nov 28, 2013 in Prostate cancer | 0 comments

In a nutshell This review investigated treatment options following biochemical recurrence after primary treatment for prostate cancer. Some background Prostate cancer can be treated using a variety of methods, the most common being partial or full removal of the prostate gland, a procedure known as a prostatectomy. Other treatments include...

Read More

Treatment or observation following detection of prostate cancer by PSA screening?

Treatment or observation following detection of prostate cancer by PSA screening?

Posted by on Jul 19, 2013 in Prostate cancer | 0 comments

In a nutshell This study used a simulation model to review the benefits and harms of either treating, or simply observing, patients diagnosed with prostate cancer by prostate specific antigen screening. Some background Prostate specific antigen (PSA) is a molecule produced by cells of the prostate gland, and is normally present at very low levels...

Read More